Inclusion in the ENDO 1000 study in the UK for multiple sample types is presented as evidence of market validation for OraSure Technologies' collection kits, as described in the Q3 2025 earnings call, ...
Portable Professional (Travel Tips with Megan) on MSN
This is what a swab test is! Know this before you fly next time
Using Your Credit Card at the Checkout Is Set to Get a Lot More Complicated Chris Hemsworth, Alzheimer's and why Hollywood is ...
BETHLEHEM, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback